These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 28516744)
41. Regional Features of MuSK Antibody-Positive Myasthenia Gravis in Northeast China. Zhang Z; Guan Y; Han J; Li M; Shi M; Deng H Front Neurol; 2020; 11():516211. PubMed ID: 33123066 [No Abstract] [Full Text] [Related]
42. Seronegative myasthenia gravis: comparison of neurophysiological picture in MuSK+ and MuSK- patients. Padua L; Tonali P; Aprile I; Caliandro P; Bartoccioni E; Evoli A Eur J Neurol; 2006 Mar; 13(3):273-6. PubMed ID: 16618345 [TBL] [Abstract][Full Text] [Related]
45. Palpebral portion of the orbicularis oculi muscle to repetitive nerve stimulation testing: A potential assessment indicator in patients with generalized myasthenia gravis. Yan C; Song J; Pang S; Yi F; Xi J; Zhou L; Ding D; Wang W; Qiao K; Zhao C J Clin Neurosci; 2018 Feb; 48():238-242. PubMed ID: 29239825 [TBL] [Abstract][Full Text] [Related]
46. Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis. Vincent A; Leite MI Curr Opin Neurol; 2005 Oct; 18(5):519-25. PubMed ID: 16155434 [TBL] [Abstract][Full Text] [Related]
47. Is paravertebral muscles edema a consequence of neurogenic changes in MuSK-positive myasthenia gravis? Bardakov SN; Tsargush VA; Carlier PG; Duc TM; Emelin AY; Polushin AY; Emelyantsev AA; Belskikh AN; Berezhnaya EN; Lapin SV; Moshnikova AN; Deev RV Acta Myol; 2022; 41(4):178-187. PubMed ID: 36793652 [TBL] [Abstract][Full Text] [Related]
50. [Ocular involvement in MuSK antibody-positive myasthenia gravis]. Bau V; Hanisch F; Hain B; Zierz S Klin Monbl Augenheilkd; 2006 Jan; 223(1):81-3. PubMed ID: 16418940 [TBL] [Abstract][Full Text] [Related]
51. Characteristics Of acetylcholine-receptor-antibody-negative myasthenia gravis in a South African cohort. Huda S; Woodhall MR; Vincent A; Heckmann JM Muscle Nerve; 2016 Dec; 54(6):1023-1029. PubMed ID: 27105303 [TBL] [Abstract][Full Text] [Related]
52. Decremental response of the nasalis and hypothenar muscles in myasthenia gravis. Niks EH; Badrising UA; Verschuuren JJ; Van Dijk JG Muscle Nerve; 2003 Aug; 28(2):236-8. PubMed ID: 12872330 [TBL] [Abstract][Full Text] [Related]
53. Are MuSK antibodies the primary cause of myasthenic symptoms? Selcen D; Fukuda T; Shen XM; Engel AG Neurology; 2004 Jun; 62(11):1945-50. PubMed ID: 15184594 [TBL] [Abstract][Full Text] [Related]
54. Myopathic changes detected by quantitative electromyography in patients with MuSK and AChR positive myasthenia gravis. Nikolic A; Basta I; Stojanovic VR; Stevic Z; Peric S; Lavrnic D J Clin Neurosci; 2016 May; 27():126-9. PubMed ID: 26778359 [TBL] [Abstract][Full Text] [Related]
59. Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis. Damato V; Spagni G; Monte G; Woodhall M; Jacobson L; Falso S; Smith T; Iorio R; Waters P; Irani SR; Vincent A; Evoli A J Neurol Neurosurg Psychiatry; 2022 Sep; 93(9):995-1000. PubMed ID: 35835469 [TBL] [Abstract][Full Text] [Related]
60. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis. Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]